Élan Corporation was a biopharmaceutical company based in Dublin, Ireland, known for developing innovative therapies for neurological and autoimmune diseases. Founded in 1969, the company focused on research and development, particularly in the areas of Alzheimer's disease and multiple sclerosis. In 2014, Élan Corporation was acquired by Perrigo Company, a global healthcare supplier. The acquisition aimed to enhance Perrigo's portfolio and expand its presence in the pharmaceutical market. Following the acquisition, Élan's operations were integrated into Perrigo, marking the end of its independent existence.